Funding
$8M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Conventional surgical blades with rough edges can cause excessive tissue trauma during incisions, leading to increased inflammation, delayed healing, and more noticeable scarring. This can negatively impact patient outcomes and increase post-operative complications.
Solution
Planatome provides nano-polished surgical blades that minimize tissue damage during surgery, leading to improved patient outcomes. By adapting chemical mechanical planarization (CMP) technology from the semiconductor industry, Planatome creates blades with ultra-smooth cutting edges, reducing surface roughness by up to 1,000x compared to traditional blades. This results in cleaner, more precise incisions with less inflammation, faster healing, and reduced scarring. Planatome's technology extends to various surgical cutting tools, offering clinical, economic, and competitive advantages for surgeons and healthcare facilities.
Target Audience
The primary target audience includes surgeons across various specialties such as plastic surgery, ophthalmic, orthopedic, cardiovascular, and neurosurgery, as well as healthcare facilities seeking to improve patient outcomes and reduce costs.
Features
- Nano-polished cutting edges achieved through chemical mechanical planarization (CMP)
- Up to 1,000x reduction in surface roughness compared to conventional blades
- Demonstrated 90% wound closure within 72 hours in clinical studies
- 86% reduction in scarring observed in facelift surgery patients
- Improved nerve recovery and reduced tissue inflammation
- Enhanced blade durability, reducing the need for frequent blade exchanges during procedures
- Seamless integration with standard surgical handles